From the Editor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

From the Editor

An FDA Seal of Approval for Online Information?

December 2, 2009

Pharmaceutical Technology

With so many healthcare and pharmacy websites, consumers could use the agency's nod of support.

With thanks

December 1, 2009

Pharmaceutical Technology Europe

It's the end of the year already and I hope you are looking forward to the festive period and the opportunity to wind down and spend some quality time with family and friends.

DIY Healthcare Reform

November 2, 2009

Pharmaceutical Technology

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.

Have your say

November 1, 2009

Pharmaceutical Technology Europe

November is finally upon us and the days are getting colder and shorter.

MRT coming soon to a plant near you

October 1, 2009

Pharmaceutical Technology Europe

Well, the summer's well and truly behind us and Madrid beckons for this year's CPhI Worldwide.

Quality by Enforcement

September 2, 2009

Pharmaceutical Technology

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

Strength in numbers

September 1, 2009

Pharmaceutical Technology Europe

Merger, union, alliance, partnership, collaboration: five words that ultimately suggest the strengthening of something.

Of Hubris and Happy Endings

August 2, 2009

Pharmaceutical Technology

Individuals and companies at the top seem to have no problem short-circuiting their success.

The Good Society

July 2, 2009

Pharmaceutical Technology

Is it good policy to pay for bad behavior?

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
17%
Protecting the supply chain
50%
Expedited reviews of drug submissions
0%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here